Bio-Techne Declares New Dividend for Shareholders
Bio-Techne Corporation (NASDAQ: TECH) has made a significant move to support its shareholders by declaring a dividend of $0.08 per share. This decision was made by the Board of Directors to promote shareholder value and demonstrate confidence in the company’s ongoing performance and financial health.
Quarterly Dividend Details
The announced dividend is for the quarter ending on June 30. Shareholders on record will be eligible to receive this dividend on August 29. This move signifies Bio-Techne's commitment to returning value to its shareholders regularly. The Board of Directors plans to evaluate future dividends quarterly, offering potential for ongoing returns.
Understanding Bio-Techne’s Mission
Bio-Techne Corporation is a premier global life sciences firm known for its innovative tools and bioactive reagents. The company plays a crucial role in scientific research and clinical diagnostics. Its products facilitate groundbreaking investigations related to biological processes and various diseases. Moreover, Bio-Techne contributes to drug discovery, providing essential tools for accurate clinical testing and diagnoses.
Financial Performance of Bio-Techne
In the most recent fiscal year, Bio-Techne reported net sales of approximately $1.2 billion, highlighting its strong market performance and robust demand for its extensive product portfolio. The company also boasts a workforce of around 3,100 employees, who are integral to its success worldwide.
Growth Strategies and Future Outlook
With an extensive range of offerings, Bio-Techne aims to expand its reach within the life sciences domain continually. The organization focuses on innovation, ensuring it remains at the forefront of scientific advancement. The strategic development of new products and operational improvements are part of Bio-Techne's agenda, aimed at further solidifying its market positioning.
Commitment to Shareholders
By instituting a quarterly dividend policy, Bio-Techne reinforces its commitment to its investors while also showcasing a healthy cash flow that supports future growth initiatives. As the business evolves, investors can look forward to regular assessments of dividend payouts as a key component of the company’s financial strategy.
Contact Information for Investor Relations
For any inquiries, David Clair, Vice President of Investor Relations and Corporate Development, is available to provide further insights into Bio-Techne's strategies and shareholder practices. You can reach the team at 612-656-4416.
Frequently Asked Questions
1. What dividend amount did Bio-Techne announce?
Bio-Techne announced a dividend of $0.08 per share for the upcoming quarter.
2. When will the dividend be payable?
The dividend will be payable on August 29 to all common shareholders of record.
3. What is the significance of this dividend declaration?
This declaration is an indication of Bio-Techne’s commitment to its shareholders and effective financial management.
4. How much did Bio-Techne earn last fiscal year?
Bio-Techne generated approximately $1.2 billion in net sales during the last fiscal year.
5. Who can I contact for more information?
For inquiries, you can contact David Clair, Vice President of Investor Relations, at 612-656-4416.
